Prefeasibility Reports
Prefeasibility Reports
Sale
The Expert Market Research report, titled “Vilazodone (Viibryd) Manufacturing Plant Project Report 2024 Edition: Industry Trends, Capital Investment, Price Trends, Manufacturing Process, Raw Materials Requirement, Plant Setup, Operating Cost, and Revenue Statistics,” provides an in-depth and comprehensive examination of the financial and operational aspects of establishing vilazodone (Viibryd) plant.
The report is the result of extensive primary and secondary research, offering a detailed analysis of current market trends, including the effects of COVID-19 on both global and regional scales. It profiles key industry players, giving insights into their market strategies, production capacities, and financial performance, which are crucial for benchmarking and competitive analysis.
It delves into historical, current, and forecasted price trends, helping stakeholders understand market dynamics and price volatility. The report provides a thorough analysis of the mass balance and raw materials requirements, ensuring a clear understanding of the input-output ratios essential for efficient production. Detailed examinations of the various unit operations integral to the vilazodone (Viibryd) manufacturing process are included, highlighting process optimisation techniques and technological advancements.
The report presents a comprehensive capital cost analysis, detailing the financial investment required for setting up a vilazodone (Viibryd) plant. This includes an exhaustive breakdown of costs associated with raw materials, catchem, utilities, labour, packaging, transportation, land acquisition, construction, and machinery. Additionally, it offers an in-depth look at the operating costs, providing clarity on the recurring expenses involved in running the plant.
Projected profit margins and optimal product pricing strategies are outlined, offering guidance on maximising profitability. The report also addresses regulatory frameworks, environmental impacts, and sustainability measures pertinent to the vilazodone (Viibryd) industry.
Vilazodone (Viibryd) is an antidepressant medication used to treat major depressive disorder in adults. It works by inhibiting serotonin reuptake and partially agonizing 5-HT1A receptors. Viibryd is taken once daily with food. Vilazodone was approved by the FDA in 2011 as a novel antidepressant option. Vilazodone has a boxed warning for an increased risk of suicidal thoughts and behaviours in certain people, especially those under 25. Dosage can range from 10-80 mg/day, depending on individual response and potential drug interactions.
Vilazodone is the active pharmaceutical ingredient (API) in the antidepressant medication Viibryd. The API is a white to cream-colored solid that exists in multiple polymorphic forms, with Form IV chosen for commercial development. It is taken once daily with food, starting at 10 mg and titrating up to 40 mg. Vilazodone has a bioavailability of 72%, an elimination half-life of 25 hours, and a solubility of 0.32 mg/mL in water at 20°C. Common side effects include nausea, diarrhoea, and insomnia, while serious potential side effects involve increased suicidal thoughts, serotonin syndrome, and bleeding. Vilazodone may offer advantages over other antidepressants by causing less emotional blunting.
Key steps in the manufacturing process of Vilazodone include reacting a compound of formula II with a source of ammonia to obtain the Vilazodone base. This base is then converted to its hydrochloride salt form. The Vilazodone active pharmaceutical ingredient (API) is formulated into 10 mg, 20 mg, and 40 mg oral tablets by combining the API with excipients such as microcrystalline cellulose, lactose monohydrate, sodium starch glycolate, magnesium stearate, and Opadry II. Stability studies have been conducted on batches of the API and drug product to support the commercial manufacturing process and formulation. The finished tablets are packaged for distribution as the prescription medication Viibryd.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Step 1: Synthesis of 5-Bromo-1H-indole
1. Starting Materials:
2. Reaction:
Step 2: Synthesis of 5-(4-Chlorobutyl)-1H-indole
1. Starting Materials:
2. Reaction:
Step 3: Synthesis of 5-(4-Chlorobutyl)-1H-indol-3-yl Acetate
1. Starting Materials:
2. Reaction:
Step 4: Synthesis of Vilazodone
1. Starting Materials:
2. Reaction:
Final Product:
Vilazodone (Viibryd), with a chemical formula of C26H27ClN4O2.
Vilazodone (Viibryd) is an antidepressant medication used to treat major depressive disorder (MDD), which is a common and debilitating mental health condition, affecting around 121 million people worldwide. Market analysis indicates the vilazodone/Viibryd market is expected to grow annually with a high growth rate, driven by factors like the high prevalence of depression and the need for new treatment options.
This production cost analysis report by Expert Market Research scrutinises the vilazodone (Viibryd) manufacturing process, offering a comprehensive overview necessary for stakeholders considering venturing into this sector. Based on the latest economic data, the report encompasses detailed insights into the primary process flow, raw material requirements, reactions involved, utility costs, operating costs, capital investments, pricing strategies, and profit margins. This report is an indispensable resource for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake in the vilazodone (Viibryd) industry. It equips them with essential information and strategic insights to effectively navigate the complexities of the market.
The following sections detail the comprehensive scope of the prefeasibility report for a vilazodone (Viibryd) production plant:
This prefeasibility report aims to equip potential investors and existing manufacturers with crucial insights to make informed decisions in the vilazodone (Viibryd) industry.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Research Methodology
3 Executive Summary
3.1 Market Trends
3.2 Raw Material Requirements
3.3 Income Projections
3.4 Expenditure Projections
3.5 Profit Analysis
4 Global Vilazodone (Viibryd) Market
4.1 Market Overview
4.2 Global Vilazodone (Viibryd) Historical Market (2018-2023)
4.3 Global Vilazodone (Viibryd) Market Forecast (2024-2032)
4.4 Global Vilazodone (Viibryd) Market Breakup by Segment
4.5 Global Vilazodone (Viibryd) Market Breakup by Region
4.6 Price Trends
4.6.1 Vilazodone (Viibryd) Price Trends
4.6.2 Product Margins
4.7 Competitive Landscape
4.7.1 Market Structure
4.7.2 Key Players
4.7.3 Profiles of Key Players
5 Vilazodone (Viibryd) Manufacturing Process
5.1 Product Overview
5.2 Detailed Process Flow
5.3 Various Types of Unit Operations Involved
5.4 Mass Balance and Raw Material Requirements
6 Production Cost Analysis
6.1 Raw Material Cost Analysis
6.1.1 Raw Material Suppliers
6.1.2 Price Trend of Raw Materials Required
6.1.3 Total Expense on Raw Materials
6.2 Utility Cost Analysis
6.2.1 Electricity Costs
6.2.2 Steam Costs
6.2.3 Process Water Costs
6.2.4 Total Expense on Utilities
6.3 Operating Cost Analysis
6.3.1 Salaries and Wages
6.3.2 Plant Overheads
6.3.3 Tax and Insurance
6.3.4 Packaging Costs
6.3.5 Transportation Costs
6.3.6 Sales and Administration Costs
6.3.7 Total Operating Costs
6.4 Capital Cost Analysis
6.4.1 Land and Site Development Costs
6.4.2 Civil Work Costs
6.4.3 Plant Machinery and Commissioning Costs
6.4.3.1 Plant Machinery Suppliers
6.4.3.2 Plant Machinery Costs
6.4.3.3 Auxiliary Equipment Cost
6.4.3.4 Electrical Works and Piping Costs
6.4.3.5 Other Fixed Costs
6.4.4 Working Capital Requirements for Plant Operation
6.4.5 Total Capital Investment Required
6.5 Total Production Cost
7 Loans and Financial Assistance
8 Project Economics
8.1 Capital Cost of the Project
8.2 Techno-Economic Parameters
8.3 Income Projections
8.4 Expenditure Projections
8.5 Product Pricing and Margins
8.6 Taxation
8.7 Depreciation
8.8 Financial Analysis
9 Regulatory Procedures and Approval
10 Key Success and Risk Factors
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.